Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function
- PMID: 10631573
- DOI: 10.1016/S0171-2985(99)80064-3
Cell-mediated immunity to Toxoplasma gondii: initiation, regulation and effector function
Abstract
Cell-mediated immune responses are essential for host control of intracellular infections. Toxoplasma gondii is a protozoan parasite that infects multiple vertebrate species and invades multiple cell types. Upon initial encounter with the immune system, the parasite rapidly induces production of the type-1 promoting cytokine IL-12 most likely from a subpopulation of dendritic cells. NK and T cells are then activated and triggered to synthesize IFN-gamma, the major mediator of host resistance during the acute and chronic phases of infection. During the acute phase, a concomitant IL-10 response dampens the systemic type-1 cytokine production and prevents lethal immunopathology. Cytokine (IFN-gamma und TNF-alpha) rather than cytotoxicity-based effector functions are more critical for protective immunity both during the acute and chronic phases of T. gondii infection. Both hemopoietic and non-hemopoietic cellular elements act as IFN-gamma and TNF-dependent effectors of host resistance. Type II iNOS-derived nitric oxide (NO) is required mainly for hemopoietic cell-derived effector cell activity in the central nervous system (CNS) during the chronic phase of infection. Nevertheless, in both the acute and chronic stages, IFN-gamma-dependent but iNOS-independent mechanism(s) play a major function in parasite control and their identification remains an important challenge for this field.
Similar articles
-
Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-gamma- and tumor necrosis factor (TNF)-alpha-dependent host resistance to the intracellular pathogen, Toxoplasma gondii.J Exp Med. 1999 Apr 5;189(7):1083-92. doi: 10.1084/jem.189.7.1083. J Exp Med. 1999. PMID: 10190899 Free PMC article.
-
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.J Immunol. 1996 Jul 15;157(2):798-805. J Immunol. 1996. PMID: 8752931
-
[Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].Verh Dtsch Ges Pathol. 1998;82:9-22. Verh Dtsch Ges Pathol. 1998. PMID: 10095413 German.
-
Ignition of the type 1 response to intracellular infection by dendritic cell-derived interleukin-12.Eur Cytokine Netw. 1998 Sep;9(3 Suppl):65-8. Eur Cytokine Netw. 1998. PMID: 9831188 Review.
-
Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis.Immunobiology. 1999 Dec;201(2):255-71. doi: 10.1016/S0171-2985(99)80066-7. Immunobiology. 1999. PMID: 10631575 Review.
Cited by
-
Toxoplasma gondii-infected human myeloid dendritic cells induce T-lymphocyte dysfunction and contact-dependent apoptosis.Infect Immun. 2002 Apr;70(4):1750-60. doi: 10.1128/IAI.70.4.1750-1760.2002. Infect Immun. 2002. PMID: 11895936 Free PMC article.
-
Secretory Microneme Proteins Induce T-Cell Recall Responses in Mice Chronically Infected with Toxoplasma gondii.mSphere. 2019 Feb 27;4(1):e00711-18. doi: 10.1128/mSphere.00711-18. mSphere. 2019. PMID: 30814319 Free PMC article.
-
IL-2 produced by CD8+ immune T cells can augment their IFN-γ production independently from their proliferation in the secondary response to an intracellular pathogen.J Immunol. 2013 Mar 1;190(5):2199-207. doi: 10.4049/jimmunol.1202256. Epub 2013 Jan 28. J Immunol. 2013. PMID: 23359502 Free PMC article.
-
Protective immunity induced by DNA vaccine containing TgGRA35, TgGRA42, and TgGRA43 against Toxoplasma gondii infection in Kunming mice.Front Cell Infect Microbiol. 2023 Oct 31;13:1236130. doi: 10.3389/fcimb.2023.1236130. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 38029261 Free PMC article.
-
Maternal Immune Response During Pregnancy and Vertical Transmission in Human Toxoplasmosis.Front Immunol. 2019 Feb 21;10:285. doi: 10.3389/fimmu.2019.00285. eCollection 2019. Front Immunol. 2019. PMID: 30846989 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical